Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Biocept's Liquid Biopsy CTC Testing ...||12/03/19|
|Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable informati...|
|Biocept Announces the Launch of its Liqu...||11/21/19|
|SAN DIEGO, Nov. 21, 2019 /PRNewswire/ -- Biocept, Inc. (BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians wit...|
|Date||2019-11-13 (AMC)||Est. (EPS/Rev.)||($0.27)/ 1.45M|
|Actual (EPS/Rev.)||$-0.25/ $1.53 M||EPS (TTM)||0|